BioInsights explores AI use cases from biologics for CGT manufacturing
It argues that CGT manufacturers should adopt electronic batch records and cloud data pipelines before advanced AI, planning early for GMP validation.
See the latest news and media coverage for BioInsights. We track all announcements, press releases, and industry mentions in real time, all in one place.
Expert-led content on translation and commercialization in life sciences
insights.bioLast updated
In short: BioInsights announced a strategic alliance with JennyCo and expanded its scientific coverage of oncology trials and genetic therapies.
It argues that CGT manufacturers should adopt electronic batch records and cloud data pipelines before advanced AI, planning early for GMP validation.
He discusses challenges like impurity separation, chromatography-induced aggregation, and continuous bioprocessing.
Experts discuss strategies from development to GMP to improve yield and purity without compromising infectivity.
Despite therapy advances, generating evidence to transform care remains a key hurdle for rare disease treatments.
BioInsights offers an all-in-one functional medicine platform that simplifies diagnostics, treatment planning, and fulfillment for healthcare providers. Their services include the Predictive Dysfunction Index (PDI...
Track BioInsights and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.